Literature DB >> 1625682

Effects of vanadyl derivatives on animal models of diabetes.

G Cros1, J J Mongold, J J Serrano, S Ramanadham, J H McNeill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1625682     DOI： 10.1007/bf00229771

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN： 0300-8177            Impact factor:   3.396


× No keyword cloud information.
  31 in total

1.  Long term improvement of glucose homeostasis by vanadate treatment in diabetic rats.

Authors:  S M Brichard; W Okitolonda; J C Henquin
Journal:  Endocrinology       Date:  1988-10       Impact factor: 4.736

2.  The insulin-like effect of vanadate on lipolysis in rat adipocytes is not accompanied by an insulin-like effect on tyrosine phosphorylation.

Authors:  R A Mooney; K L Bordwell; S Luhowskyj; J E Casnellie
Journal:  Endocrinology       Date:  1989-01       Impact factor: 4.736

3.  Effects of vanadium on glucose metabolism in vitro.

Authors:  E L Tolman; E Barris; M Burns; A Pansini; R Partridge
Journal:  Life Sci       Date:  1979-09-24       Impact factor: 5.037

4.  Electron paramagnetic resonance studies and insulin-like effects of vanadium in rat adipocytes.

Authors:  H Degani; M Gochin; S J Karlish; Y Shechter
Journal:  Biochemistry       Date:  1981-09-29       Impact factor: 3.162

5.  Selectivity of the insulin-like actions of vanadate on glucose and protein metabolism in skeletal muscle.

Authors:  A S Clark; J M Fagan; W E Mitch
Journal:  Biochem J       Date:  1985-11-15       Impact factor: 3.857

6.  Oral vanadyl sulfate in treatment of diabetes mellitus in rats.

Authors:  S Ramanadham; J J Mongold; R W Brownsey; G H Cros; J H McNeill
Journal:  Am J Physiol       Date:  1989-09

7.  Vanadate treatment of streptozotocin diabetic rats restores expression of the insulin-responsive glucose transporter in skeletal muscle.

Authors:  H V Strout; P P Vicario; C Biswas; R Saperstein; E J Brady; P F Pilch; J Berger
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

8.  Effects of chronic administration of vanadate to the rat on the sensitivity of glycolysis and glycogen synthesis in skeletal muscle to insulin.

Authors:  R A Challiss; B Leighton; F J Lozeman; L Budohoski; E A Newsholme
Journal:  Biochem Pharmacol       Date:  1987-02-01       Impact factor: 5.858

9.  Peroxide(s) of vanadium: a novel and potent insulin-mimetic agent which activates the insulin receptor kinase.

Authors:  S Kadota; I G Fantus; G Deragon; H J Guyda; B Hersh; B I Posner
Journal:  Biochem Biophys Res Commun       Date:  1987-08-31       Impact factor: 3.575

10.  Effect of vanadate on elevated blood glucose and depressed cardiac performance of diabetic rats.

Authors:  C E Heyliger; A G Tahiliani; J H McNeill
Journal:  Science       Date:  1985-03-22       Impact factor: 47.728
View more
  6 in total

1.  In vivo effects of vanadate on hepatic glycogen metabolizing and lipogenic enzymes in insulin-dependent and insulin-resistant diabetic animals.

Authors:  R L Khandelwal; S Pugazhenthi
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 2.  Antihypertensive effects of vanadium compounds in hyperinsulinemic, hypertensive rats.

Authors:  S Bhanot; A Michoulas; J H McNeill
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  In vivo effects of peroxovanadium compounds in BB rats.

Authors:  J F Yale; C Vigeant; C Nardolillo; Q Chu; J Z Yu; A Shaver; B I Posner
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

Review 4.  Toxicology of vanadium compounds in diabetic rats: the action of chelating agents on vanadium accumulation.

Authors:  J L Domingo; M Gomez; D J Sanchez; J M Llobet; C L Keen
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

5.  Effect of oral vanadyl sulfate treatment on serum enzymes and lipids of streptozotocin-diabetic young rats.

Authors:  M T Pepato; M R Magnani; I C Kettelhut; I L Brunetti
Journal:  Mol Cell Biochem       Date:  1999-08       Impact factor: 3.396

6.  Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy.

Authors:  U O Wenzel; B Fouqueray; P Biswas; G Grandaliano; G G Choudhury; H E Abboud
Journal:  J Clin Invest       Date:  1995-03       Impact factor: 14.808
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.